[go: up one dir, main page]

ATE115143T1 - N-(PYRIDINYL)-1H-INDOL-1-AMINES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS MEDICINES. - Google Patents

N-(PYRIDINYL)-1H-INDOL-1-AMINES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS MEDICINES.

Info

Publication number
ATE115143T1
ATE115143T1 AT88106121T AT88106121T ATE115143T1 AT E115143 T1 ATE115143 T1 AT E115143T1 AT 88106121 T AT88106121 T AT 88106121T AT 88106121 T AT88106121 T AT 88106121T AT E115143 T1 ATE115143 T1 AT E115143T1
Authority
AT
Austria
Prior art keywords
loweralkyl
arylloweralkyl
sec
aryl
halogen
Prior art date
Application number
AT88106121T
Other languages
German (de)
Inventor
Richard Charles Effland
Joseph Thomas Klein
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Application granted granted Critical
Publication of ATE115143T1 publication Critical patent/ATE115143T1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

There are disclosed compounds of the formula <CHEM> where m is 1 or 2; n is 1 or 2; P is 0 or 1; each R is independently hydrogen, halogen, loweralkyl, loweralkoxy, hydroxy, nitro, amino, loweralkylamino, loweralkylcarbonylamino, cyano, formyl, loweralkoxycarbonyl, loweralkylthio or loweralkoxycarbonylloweralkylthio; each R1 is independently hydrogen, loweralkyl, loweralkenyl, formyl, loweralkylcarbonyl, arylloweralkylcarbonyl, arylcarbonyl, halogen, arylloweralkenyl, arylloweralkyl, heteroarylloweralkenyl, heteroarylloweralkyl, cyanoloweralkenyl, cyanoloweralkyl, methoxyloweralkenyl, methoxyloweralkyl, loweralkoxycarbonylloweralkenyl, loweralkoxycarbonylloweralkyl, cycloalkylloweralkenyl or cycloalkylloweralkyl, the term heteroaryl signifying a group of the formula <CHEM> where W is O, S, NH or CH=N, cyano, -CH(OH)R4, -C(OH)R4R5 or -CH2OR5, R4 being hydrogen, loweralkyl, arylloweralkyl or aryl and R5 being loweralkyl, arylloweralkyl or aryl; each R2 is independently hydrogen, loweralkyl, loweralkenyl, loweralkynyl, loweralkoxycarbonylloweralkyl, loweralkylaminocarbonylloweralkyl, aminocarbonylloweralkyl, arylloweralkyl, phenyl, nitrophenyl, cyanophenyl, trifluoromethylphenyl, aminophenyl, loweralkanoylaminophenyl, loweralkoxycarbonyl, arylloweralkoxycarbonyl, aryloxycarbonyl, loweralkylaminocarbonyl, arylloweralkylaminocarbonyl, arylaminocarbonyl, alkanoyl, arylloweralkanoyl, aroyl, alkenoyl, alkynoyl or -R6-NR min R sec where R6 is loweralkylene, loweralkenylene or loweralkynylene and R min and R sec are each independently loweralkyl or alternatively the group -NR min R sec as a whole is 1-pyrrolidinyl, 1-piperidinyl, 4-morpholinyl, 4-loweralkyl-1-piperazinyl or 4-aryl-1-piperazinyl; and R3 is hydrogen, nitro, amino, halogen, loweralkanoylamino, arylloweralkanoylamino, aroylamino, alkylamino, arylloweralkylamino or loweralkyl and a process for their preparation. The compounds are useful for enhancing memory and also as analgesic and antidepressant agents.
AT88106121T 1987-04-24 1988-04-18 N-(PYRIDINYL)-1H-INDOL-1-AMINES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS MEDICINES. ATE115143T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4207987A 1987-04-24 1987-04-24

Publications (1)

Publication Number Publication Date
ATE115143T1 true ATE115143T1 (en) 1994-12-15

Family

ID=21919923

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88106121T ATE115143T1 (en) 1987-04-24 1988-04-18 N-(PYRIDINYL)-1H-INDOL-1-AMINES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS MEDICINES.

Country Status (17)

Country Link
EP (1) EP0287982B1 (en)
JP (1) JP2683360B2 (en)
KR (1) KR960015003B1 (en)
AT (1) ATE115143T1 (en)
AU (1) AU594876B2 (en)
CA (1) CA1330661C (en)
DE (1) DE3852335T2 (en)
DK (1) DK172153B1 (en)
ES (1) ES2065324T3 (en)
FI (1) FI90978C (en)
IE (1) IE65349B1 (en)
IL (1) IL86154A (en)
NO (1) NO168104C (en)
NZ (1) NZ224338A (en)
PH (1) PH26127A (en)
PT (1) PT87308B (en)
ZA (1) ZA882810B (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868190A (en) * 1988-12-27 1989-09-19 Hoechst-Roussel Pharmaceuticals, Inc. N-pyridinyl-9H-carbazol-9-amines
US4983615A (en) * 1989-06-28 1991-01-08 Hoechst-Roussel Pharmaceuticals Inc. Heteroarylamino- and heteroaryloxypyridinamine compounds which are useful in treating skin disorders
US5179119A (en) * 1989-08-02 1993-01-12 Hoechst-Roussel Pharmaceuticals Incorporated 1,3-dihydro-1-(pyridinylamino)-2H-indol-1-ones and intermediates for the preparation thereof
EP0415103B1 (en) * 1989-08-02 1995-02-01 Hoechst-Roussel Pharmaceuticals Incorporated 2,3-Dihydro-1-(pyridinylamino)-indoles, a process for their preparation and their use as medicaments
US5179099A (en) * 1989-08-02 1993-01-12 Hoechst-Roussel Pharmaceuticals Incorporated 2,3-dihydro-1-(pyridinylamino)-indoles
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones
US4983608A (en) 1989-09-05 1991-01-08 Hoechst-Roussell Pharmaceuticals, Inc. N-substituted-4-pyrimidinamines and pyrimidinediamines
US5102891A (en) * 1990-07-23 1992-04-07 Hoechst-Roussel Pharmaceuticals Inc. 1-(substituted pyridinylamino)-1H-indol-5-yl substituted carbamates
US5214038A (en) * 1991-04-15 1993-05-25 Hoechst-Roussel Pharmaceuticals Inc. 1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles and intermediates for the preparation thereof
US5328920A (en) * 1991-04-17 1994-07-12 Hoechst-Roussel Pharmaceuticals Incorporated Substituted (pyridinylamino)-indoles
US5185350A (en) * 1991-09-23 1993-02-09 Hoechst-Roussel Pharmaceuticals Incorporated Substituted pyridinylamino-1h-indoles,1h-indazoles,2h-indazoles, benzo (b)thiophenes and 1,2-benzisothiazoles
US5356910A (en) * 1993-07-19 1994-10-18 Hoechst-Roussel Pharmaceuticals Inc. Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder
US5459274A (en) * 1994-05-13 1995-10-17 Hoechst-Roussel Pharmaceuticals Inc. Preparation of N-alkyl-N-pyridinyl-1H-indol-1-amines
ATE218343T1 (en) * 1995-07-27 2002-06-15 Aventis Pharma Inc USE OF SUBSTITUTED AND UNSUBSTITUTED N-(PYRROL-1-YL)PYRIDINAMINES AS ANTICONVULSIVES
HUP9802413A3 (en) * 1995-07-27 2002-02-28 Aventis Pharmaceuticals Inc Br Use of n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents and for the preparation of a pharmaceutical composition for the treatment of convulsions
HUP0000783A2 (en) * 1996-12-27 2001-04-28 Hoechst Marion Roussel, Inc. N-(pyridinylamino)isoindolines and their derivatives, process for their production, pharmaceutical preparations containing these compounds and their use
JP4683166B2 (en) * 1999-03-10 2011-05-11 東ソー株式会社 Method for producing nitrogen-containing heterocyclic compound
DE60016068T2 (en) 1999-03-10 2005-11-03 Tosoh Corp., Shinnanyo Process for the preparation of nitrogen heterocyclic compounds
JP4779185B2 (en) * 1999-03-10 2011-09-28 東ソー株式会社 Nitrogen-containing heterocyclic compound and method for producing the same
GB0119435D0 (en) * 2001-02-15 2001-10-03 Aventis Pharm Prod Inc Method of treating of demyelinating diseases or conditions
US7538227B2 (en) 2004-01-13 2009-05-26 Sanofi-Aventis Deutschland Gmbh Process for stabilizing 4-halopyridines
GT200500063A (en) * 2004-04-01 2005-10-14 METHOD FOR TREATMENT OF SCHIZOPHRENIA AND / OR GLUCOREGULATORY ABNORMALITIES
FR2888238B1 (en) * 2005-07-07 2007-09-07 Servier Lab NOVEL 1H-INDOLE-PYRIDINECARBOXAMIDE AND 1H-INDOLE-PIPERIDINECARBOXAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARCEUMATIC COMPOSITIONS CONTAINING THEM
FR2911780A1 (en) * 2007-01-26 2008-08-01 Urogene TREATMENT OF FECAL INCONTINENCE.
KR20100015546A (en) * 2007-04-13 2010-02-12 사노피-아벤티스 A transition metal catalyzed synthesis of n-aminoindoles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3242185A (en) * 1963-10-07 1966-03-22 Merck & Co Inc Lower aliphatic acids, salts and derivatives thereof
DE1670184A1 (en) * 1967-01-20 1971-01-21 Boehringer Sohn Ingelheim Process for the preparation of heterocyclically substituted hydrazino-imidazoline- (2)
CH603581A5 (en) * 1974-03-29 1978-08-31 Siegfried Ag
US4260767A (en) * 1979-12-26 1981-04-07 American Cyanamid Company 2-Pyridylhydrazides
US4792562A (en) * 1985-12-04 1988-12-20 Hoechst-Roussel Pharmaceuticals, Inc. N-(pyrrol-1-yl)pyridinamines having memory enhancing activity

Also Published As

Publication number Publication date
CA1330661C (en) 1994-07-12
PH26127A (en) 1992-02-24
KR880012591A (en) 1988-11-28
JPS63280079A (en) 1988-11-17
EP0287982B1 (en) 1994-12-07
JP2683360B2 (en) 1997-11-26
PT87308A (en) 1988-05-01
NO168104B (en) 1991-10-07
AU594876B2 (en) 1990-03-15
NO881776L (en) 1988-10-25
DK172153B1 (en) 1997-12-01
FI90978B (en) 1994-01-14
EP0287982A3 (en) 1991-03-27
FI90978C (en) 1994-04-25
ZA882810B (en) 1988-10-20
DE3852335T2 (en) 1995-05-11
IL86154A (en) 1992-03-29
ES2065324T3 (en) 1995-02-16
PT87308B (en) 1992-08-31
AU1510088A (en) 1988-10-27
DK223488D0 (en) 1988-04-22
FI881874A7 (en) 1988-10-25
NZ224338A (en) 1991-07-26
FI881874A0 (en) 1988-04-21
IE65349B1 (en) 1995-10-18
IE881213L (en) 1988-10-24
DE3852335D1 (en) 1995-01-19
DK223488A (en) 1988-10-25
NO168104C (en) 1992-01-15
EP0287982A2 (en) 1988-10-26
NO881776D0 (en) 1988-04-22
IL86154A0 (en) 1988-11-15
KR960015003B1 (en) 1996-10-23

Similar Documents

Publication Publication Date Title
ATE115143T1 (en) N-(PYRIDINYL)-1H-INDOL-1-AMINES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS MEDICINES.
HU912756D0 (en) Process for producing 6,7-dihydro-3-phenyl-1,2-benz-isoxazole-4(5h)-ones and -oles as well as pharmaceutical preparatives containing said compounds
AU8121691A (en) 1-(substituted pyridinylamino)-1h-indole-5-yl substituted carbamates, a process and intermediates for their preparation and their use as medicaments
ATE168689T1 (en) SUBSTITUTED (PYRIDINYLAMINO)-BENZISOXAZOLES AND -BENZISOTHIAZOLES, A PROCESS FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS
IL85401A0 (en) 9-amino-1,4-ethano-1,2,3,4-tetra-hydroacridine and related compounds,process for their preparation and pharmaceutical compositions containing same
DE3853895D1 (en) Substituted 9-amino-spiro [cycloalkyl [b] quinoline-2,1&#39;cycloalkanes], processes and intermediates for their preparation and their use as medicaments.
ATE92046T1 (en) 9-HYDROXYAMINO-TETRAHYDROACRIDINE, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICATIONS.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time